A mechanism for localized dynamics-driven activation in Bruton's tyrosine kinase

被引:2
|
作者
Qiu, Simei [1 ,2 ]
Liu, Yunfeng [1 ]
Li, Quhuan [1 ,2 ,3 ]
机构
[1] South China Univ Technol, Inst Biomech, Sch Biosci & Bioengn, Guangzhou, Peoples R China
[2] South China Univ Technol, Guangdong Prov Engn & Technol Res Ctr Biopharmace, Guangzhou, Peoples R China
[3] South China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China
来源
ROYAL SOCIETY OPEN SCIENCE | 2021年 / 8卷 / 08期
基金
中国国家自然科学基金;
关键词
activation mechanism; Bruton's tyrosine kinase; T474M mutation; X-LINKED AGAMMAGLOBULINEMIA; IRREVERSIBLE INHIBITORS; TARGETING BTK; IBRUTINIB; DISCOVERY; MUTATION; PATHWAY; BINDING; CANCER; CELLS;
D O I
10.1098/rsos.210066
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Bruton's tyrosine kinase (BTK) plays a vital role in mature B-cell proliferation, development and function. Its inhibitors have gradually been applied for the treatment of many B-cell malignancies. However, because of treatment-associated drug resistance or low efficacy, it is urgent to develop new inhibitors and/or improve the efficacy of current inhibitors, where finding the intrinsic activation mechanism becomes the key to solve this problem. Here, we used BTK T474M mutation as a resistance model for inhibitors to study the mechanism of BTK activation and drug resistance by free molecular dynamics simulations. The results showed that the increase of kinase activity of T474M mutation is coming from the conformation change of the activation ring and ATP binding sites located in BTK N-terminus region. Specifically, the Thr(474) mutation changed the structure of A-loop and stabilized the binding site of ATP, thus promoting the catalytic ability in the kinase domain. This localized dynamics-driven activation mechanism and resistance mechanism of BTK may provide new ideas for drug development in B-cell malignancies.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Constitutive membrane association potentiates activation of Bruton tyrosine kinase
    Li, TJ
    Rawlings, DJ
    Park, H
    Kato, RM
    Witte, ON
    Satterthwaite, AB
    ONCOGENE, 1997, 15 (12) : 1375 - 1383
  • [32] Constitutive membrane association potentiates activation of Bruton tyrosine kinase
    Tianjian Li
    David J Rawlings
    Hyunsun Park
    Roberta M Kato
    Owen N Witte
    Anne B Satterthwaite
    Oncogene, 1997, 15 : 1375 - 1383
  • [33] Decoding bruton's tyrosine kinase signalling in neuroinflammation
    Gruber, R.
    Dufault, M.
    Chretien, N.
    Proto, J.
    Zhang, M.
    Lamorte, M.
    Havari, E.
    Turner, T.
    Chomyk, A.
    Christie, E.
    Trapp, B.
    Ofengeim, D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 270 - 270
  • [34] Bruton's tyrosine kinase in systemic lupus erythematosus
    Liao, Hsien-Tzung
    Tung, Hsiang-Yuen
    Tsai, Chang-Youh
    Chiang, Bor-Luen
    Yu, Chia-Li
    JOINT BONE SPINE, 2020, 87 (06) : 670 - 672
  • [35] Clinical potential of targeting Bruton's tyrosine kinase
    Uckun, Fatih M.
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2008, 27 (1-2) : 43 - 69
  • [36] Dermatological Toxicities of Bruton’s Tyrosine Kinase Inhibitors
    Vincent Sibaud
    Marie Beylot-Barry
    Caroline Protin
    Emmanuelle Vigarios
    Christian Recher
    Loic Ysebaert
    American Journal of Clinical Dermatology, 2020, 21 : 799 - 812
  • [37] Role of Bruton's tyrosine kinase in macrophage apoptosis
    Khare, Anupriya
    Viswanathan, Bharathi
    Gund, Rupali
    Jain, Nidhi
    Ravindran, Balachandran
    George, Anna
    Rath, Satyajit
    Bal, Vineeta
    APOPTOSIS, 2011, 16 (04) : 334 - 346
  • [38] Bruton's Tyrosine Kinase and Its Isoforms in Cancer
    Wang, Xianhui
    Kokabee, Leila
    Kokabee, Mostafa
    Conklin, Douglas S.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [39] Dermatological Toxicities of Bruton's Tyrosine Kinase Inhibitors
    Sibaud, Vincent
    Beylot-Barry, Marie
    Protin, Caroline
    Vigarios, Emmanuelle
    Recher, Christian
    Ysebaert, Loic
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020, 21 (06) : 799 - 812
  • [40] Bruton's tyrosine kinase: What's known now
    Kawakami, T
    Kitaura, J
    Kawakami, Y
    SEIKAGAKU, 1998, 70 (10): : 1262 - 1266